16 Sep. 2025 | 3 – 4 pm CEST
Zoom Registration
Speaker: Renate Wahl
University Hospital Aachen, Germany
Domain: Treatment/Therapy
Recent Advances in Clinical Trials in Multiple System Atrophy
Speech treatment in Ataxias
Winter school 2025 “Challenges of treating rare neurological diseases”
14 Mar. 2025
Speaker: Adam Vogel
University of Melbourne, Melbourne, Australia
Cognitive and psychiatric treatment in Huntington’s disease
Winter school 2025 “Challenges of treating rare neurological diseases”
14 Mar. 2025
Speaker: Mayke Oosterloo
Maastricht University Medical Center, The Netherlands
Treatment of ataxia – rehabilitation based
Winter school 2025 “Challenges of treating rare neurological diseases”
13 Mar. 2025
Speaker: Gabriella Paparella
IRCCS Eugenio Medea, Institute for rehabilitation medicine, Italy
Treatment of ataxia – genetics based
Winter school 2025 “Challenges of treating rare neurological diseases”
13 Mar. 2025
Speaker: Ronald Buijsen
Leiden University, The Netherlands
Treatment of spasticity in children with rare neurological disorders – who, why, when and what?
Winter school 2025 “Challenges of treating rare neurological diseases”
13 Mar. 2025
Speaker: Annemieke Buizer
Amsterdam UMC, The Netherlands
Disease-modifying treatment approaches/Trials in Huntington disease (HD)
Winter school 2025 “Challenges of treating rare neurological diseases”
12 Mar. 2025
Speaker: Bernhard Landwehrmeyer
University Hospital Ulm, Germany
Treatment of nano-rare neurological diseases
Winter school 2025 “Challenges of treating rare neurological diseases”
12 Mar. 2025
Speaker: Marlen Lauffer
Leiden University Medical Center, The Netherlands
Treatment of Aromatic l-amino acid decarboxylase (AADC) deficiency
Winter school 2025 “Challenges of treating rare neurological diseases”
12 Mar. 2025
Speaker: Thomas Opladen
University Children’s Hospital Heidelberg, Germany
Leriglitazone Trial in Adrenoleukodystrophy
Winter school 2025 “Challenges of treating rare neurological diseases”
12 Mar. 2025
Speaker: Caroline Sevin & Fanny Mochel
Kremlin-Bicêtre University Hospital & La Pitié-Salpêtrière Hospital, Paris, France
Treatment of Metachromatic Leukodystrophies
Winter school 2025 “Challenges of treating rare neurological diseases”
12 Mar. 2025
Speaker: Francesca Fumagalli
IRCCS San Raffaele Scientific Institute, Milan, Italy
DBS in Dystonia – the network perspective
The role of dopamine in the pathophysiology of the Allan-Herndon-Dudley syndrome/MCT8 deficiency
Genetic therapies and therapy developments for rare movement disorders
State of the art of clinical stage gene therapies for Leukodystrophies
Strategies of DBS Troubleshooting in Dystonia
Winter school 2024 “DBS in dystonia”
17-19 Apr. 2024
Speaker: Norbert Kovacs
Italy Azienda Ospedaliero-Universitaria Siena
MER and LFP Signals for Implantation and Programming in Dystonia Patients
Winter school 2024 “DBS in dystonia”
17-19 Apr. 2024
Speaker: Nicolo Pozzi
University of Würzburg, Germany
Neuroimaging for Implantation and Programming in Dystonia Patients
Botulinum Toxin – Opportunities and Limitation
Winter school 2024 “DBS in dystonia”
17-19 Apr. 2024
Speaker: Francesca Morgante
St George’s University Hospital London, UK
Drug Therapy and Neurorehabilitation – Opportunities and Limitations
Winter school 2024 “DBS in dystonia”
17-19 Apr. 2024
Speaker: Anna Castagna
Fondazione Don Carlo Gnocchi, Milan, Italy)
Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities
Haematopoietic Stem Cell Transplantation in Leukodystrophies
Non-pharmacological approaches to treatment in svPPA
DBS in Dystonia – Targets, programming and therapeutic challenges
Clinical and genetic predictors of subthalamic nucleus deep brain stimulation in Parkinson’s disease
27 Sep. 2022
Speaker: Daniel Weiß
Hertie Institute for Clinical Brain Research, University of Tübingen, Germany
The logopenic variant of primary progressive aphasia (lvPPA): language, cognitive, neuroradiological issues’
5 Apr. 2022
Speaker: Robert Rusina & Zsolt Cséfalvay
Thomayer Hospital, Prague, Czech Republic; Comenius University in Bratislava, Slovakia
Antisense oligonucleotide mediated exon skipping therapy development for Duchenne muscular dystrophy takes more than an oligonucleotide
ASO RNA splice modulating therapies for genetic brain disorders
Anti-spastic therapies in Hereditary Spastic Paraplegia
11 Jan. 2022
Speaker: Marcondes C. França Jr.
School of Medical Sciences, University Campinas (UNICAMP), Brasil